About
Experienced in design and synthesis of antitubercular molecules, lead identification and optimization of new chemical entities (NCEs) as antitubercular agents, multistep synthesis of biologically important antitubercular hybrids and development of new synthetic methodologies for the synthesis of bioactive and pharmaceutically important molecules.
Earlier associated as Research Scientist with the Synthesis Division of a leading CRO for 2 years where she was actively involved in the designing and synthesis of biologically important scaffolds, intermediates and reference compounds.